Indoleamine 2,3-dioxygenase 1 and Programmed Cell Death-ligand 1 Co-expression Predicts Poor Pathologic Response and Recurrence in Esophageal Squamous Cell Carcinoma after Neoadjuvant Chemoradiotherapy

This study aimed to investigate the impact of indoleamine 2,3-dioxygenase 1 (IDO1) expression, programmed cell death-ligand 1 (PD-L1) expression, CD8+ tumor-infiltrating lymphocyte (TIL) status, and their combination on pathologic complete response (pCR) and recurrence in esophageal squamous cell ca...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Sha, Zhao, Lei, Liang, Zhaohui, Liu, Songran, Li, Yong, Liu, Shiliang, Yang, Hong, Liu, Mengzhong, Xi, Mian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6406509/
https://www.ncbi.nlm.nih.gov/pubmed/30717285
http://dx.doi.org/10.3390/cancers11020169

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6406509/
https://www.ncbi.nlm.nih.gov/pubmed/30717285
http://dx.doi.org/10.3390/cancers11020169

Ejemplares similares